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Although prohibitin 1 (PHB) is known to be associated with tumors, there are few studies regarding the role of PHB in hepa-
tocellular carcinoma. An earlier glycoproteomics study of ours showed that PHB is over-expressed in MHCC97-H cells, a 
highly metastatic liver cancer cell line, and can be captured by wheat germ agglutinin. In the present study, western blotting 
and reverse transcription-PCR experiments showed an approximately 2-fold up-regulation in the expression of PHB in 
MHCC97-H cells. However, PHB was not significantly up-regulated in MHCC97-L cells, a low-metastatic liver cancer cell 
line. When PHB was over-expressed in MHCC97-L cells, cell proliferation was inhibited by 35% and migration increased 
about 2-fold. The results of this study show that PHB is up-regulated in MHCC97-H cells and is associated with both prolif-
eration and migration of liver cancer cells. 
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Prohibitin 1 (PHB) is a highly conserved protein in eu-
karyotic cells that is present in multiple cellular compart-
ments. It belongs to the prohibitin family, which comprises 
PHB and prohibitin 2. PHB has a molecular mass of about 
32 kD and prohibitin 2 has a molecular mass of about   
37 kD [1]. Together, these proteins can form a high mo-
lecular weight complex. These complexes have been iden-
tified in mitochondria [2], the plasma membrane [3] and 
the nucleus [4]. There is some controversy concerning the 
expression levels of PHB by different tumors and cell lines. 
For example, decreased expression of PHB was reported in 
human stomach adenocarcinoma tissue compared with the 
surrounding normal tissues [5]. However, a number of 
studies report high-level expression of PHB in other tumor 
tissues, such as lung cancer, prostate carcinoma [6], and rat 
bladder carcinomas [7]. Studies have also shown that PHB 
levels are higher in transformed cells and tumors than in 
their normal counterparts [7–9]. Therefore, it is possible that 
PHB expression is associated with cancer. 
In previous studies, we used wheat germ agglutinin 
(WGA) affinity chromatography to capture the N-linked 
glycoproteins expressed by Chang liver cells (immortalized 
human non-tumor liver cells) and MHCC97-H cells (a highly 
metastatic liver cancer cell line). Using two-dimensional 
electrophoresis (2-DE) and mass spectrometry (MS), we 
separated and identified five markedly up-regulated glyco-
proteins from MHCC97-H cells (published in the journal of 
Proteomics) [10]. Of these, we focused on a new glycopro-
tein, PHB.  
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The aim of the present study was to confirm that PHB 
was over-expressed in MHCC97-H cells and to study the 
role of PHB in the proliferation and migration of liver can-
cer cells. 
1  Materials and methods 
1.1  Materials 
RPMI 1640 and DMEM were purchased from Gibco (USA). 
Chang liver cells, MHCC97-H cells, and MHCC97-L cells 
were obtained from the Liver Cancer Institute, Zhongshan 
Hospital, Fudan University. An unconjugated mouse mono-
clonal anti-prohibitin 1 antibody was purchased from Novus 
Biologicals (USA) (Clone II-14-10, ab1836). Lipofectin 
2000 was purchased from Invitrogen (USA). Trizol reagent 
for total RNA extraction was purchased from Watson 
(Shanghai). RT-PCR kits, and Xba I and BamH I endonu-
cleases were obtained from Takara (Japan). The ECL detec-
tion reagent was purchased from Amersham Biosciences 
(Sweden). All other chemicals were analytical grade prod-
ucts obtained commercially. 
1.2  Cell culture 
Chang liver cells were cultured at 37°C in 5% CO2 in RPMI 
1640 supplemented with 10% newborn calf serum. 
MHCC97-H and MHCC97-L cells were established from the 
parent cell line, MHCC97. MHCC97-H cells, MHCC97-L 
cells, and other cells were cultured at 37°C in 5% CO2 in 
DMEM supplemented with 10% fetal bovine serum. 
1.3  WGA affinity chromatography, 2-DE and MS 
WGA affinity chromatography, 2-DE and MS analysis were 
performed as previously described [10]. Briefly, agarose-     
bound WGA (Vector Laboratories, Al-1023) was prepared 
and used to capture glycoproteins from the soluble fractions 
of Chang liver and MHCC97-H lysates. The eluted fractions 
were dialyzed with Milli Q water (Millipore, USA) at 4°C 
and freeze-dried. 2-DE was performed as previously de-
scribed [10] using the IPGphor IEF System and a Hoefer SE 
600 (Amersham Biosciences, Sweden). Glycoproteins (250 μg) 
were assessed by isoelectric focusing (IEF) using 13 cm pH 
3–10 NL IPG strips (Amersham Biosciences). The sepa-
rated proteins were visualized using silver diamine-staining 
as described in the Amersham 2-DE protocol. For MS de-
tection, 1 mg of glycoproteins was separated as described 
above and the proteins were stained with Coomassie Bril-
liant Blue (CBB) R250. MALDI-TOF MS and tandem 
TOF/TOF MS were performed using a 4700 
MALDI-TOF/TOF Proteomics Analyzer (Applied Biosys-
tems, USA). The measured peptide mass profiles were com-
pared with the theoretical peptide masses using the 
MASCOT (www.matrixscience.com) search engine and 
IPI-HUMAN and NCBI databases for protein identification. 
The 2-DE gels were scanned using an ImageScanner™ 
(Amersham Biosciences) and data were analyzed using Im-
ageMaster™ 2-D Platinum software (v5.0, Amersham Bio-
sciences). 
1.4  Western blot analysis 
Cells were washed three times in PBS at 4°C and lysed in 
lysis buffer (50 mmol L−1 Tris-HCl, pH 6.8, 2% SDS, 10% 
glycerol, 1 mmol L−1 PMSF, 1 μg mL−1 leupeptin, and 1 μg 
mL−1 aprotinin). Lysates were clarified by centrifugation at 
15000×g for 10 min at 4°C. The protein concentration was 
determined using a modified Lowry assay [11,12]. Proteins 
(60 μg) were run on a 10% SDS polyacrylamide gel and 
electrophoretically transferred onto a nitrocellulose mem-
brane. The membrane was blocked for 4 h in PBS contain-
ing 0.05% Tween 20 (PBST) containing 5% nonfat milk 
and incubated overnight with a mouse anti-prohibitin pri-
mary antibody (ab1836, diluted 1:1000) and a mouse anti-     
glyceraldehyde-3-phosphate dehydrogenase (GADPH, di-
luted 1:4000) antibody. After washing, the nitrocellulose 
membrane was incubated with horseradish peroxidase 
(HRP)-conjugated anti-mouse IgG (1:3000) for 4 h. After 
washing the membrane three times with PBST, proteins 
were visualized using enhanced chemiluminescence (ECL) 
detection reagents according to the manufacturer’s instruc-
tions. The results were analyzed using TotalLab software.  
1.5  Reverse transcription (RT)-PCR, plasmid con-
struction and transfections 
Total RNA samples were prepared using Trizol reagent. 
RT-PCR was carried out according to the manufacturer’s 
instructions. Briefly, 4 μg of RNA was used for the RT re-
action and 2 μL of the cDNA product was used in the PCR 
mix along with a forward primer, 5′-GCGGATCCATGG- 
CTGCCAAAGTGTTTGAGT-3′ and a reverse primer, 5′- 
GCTCTAGACTACTGGGGCAGCTGGAGGAGC-3′. Pri- 
mers for β-actin were used as an internal control. Samples 
were amplified for 30 cycles of 95°C for 30 s, 65°C for 30 s, 
and 72°C for 3 min. The PCR products were analyzed on 
1% agarose gels. PHB cDNA was amplified using PHB-     
specific primers containing Xba I and BamH I restriction 
sites. The purified 819-bp fragment and the pcDNA3.0 
vector were cut with Xba I and BamH I and ligated to yield 
the recombinant PHB expression plasmid, pcDNA3.0-PHB. 
Purified plasmid DNA was transfected into MHCC97-L 
cells using Lipofectin 2000 according to the manufacturer’s 
instructions. 
1.6  MTT assay 
A colorimetric assay using the tetrazolium salt 3-(4,5- 
Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) 
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was used to determine the effects of PHB on MHCC97-L 
cell proliferation. The MTT assay was performed as previ-
ously described [13]. Briefly, after transfection with 
pcDNA3.0 and pcDNA3.0-PHB for 12 h, an equal number 
of cells were seeded into a 96-well plate at a density of 
5×103 cells per well. After 24 h, 48 h and 72 h of incuba-
tion, 20 μL of MTT (stock solution 5 mg mL−1) was added 
to each well. After a further 4 h, DMSO (150 μL) was 
added to each well to dissolve the crystals. The optical den-
sity (A) of each well was read using an enzyme-linked 
immunosorbent assay reader (Bio-Tek, USA) at 490 nm. 
All experiments were performed in triplicate. The cell in-
hibitory ratio was calculated using the following formula: 
Inhibitory ratio = (1−A490 Treated group/A490 Control group)× 
100%.  
1.7  Transwell migration assay 
MHCC97-L cells were transfected with plasmids in se-
rum-free medium. After 24 h, a transwell assay was used to 
monitor in vitro cell migration as previously described [12]. 
Briefly, 1×104 tumor cells in 0.5% BSA-DMEM were 
placed in the upper chamber of the transwell unit and 0.5% 
BSA-DMEM containing 0.5% FBS was placed in the lower 
chamber. After a 12-h incubation at 37°C in 5% CO2 the 
cells were fixed in methanol and the upper side of the filter 
removed and gently wiped with a cotton swap. Cell migra-
tion was determined by counting the cells that migrated to 
the lower side of the polycarbonate filters using a standard 
crystal violet staining technique (the cell numbers in eight 
random areas were counted under a light microscope at ×10 
magnification). Each assay was repeated three times.  
1.8  Statistical analysis 
All data were analyzed using one-way analysis of variance 
(ANOVA) and SPSS 12.0 for Windows® software (SPSS 
Inc., USA). A P-value of >0.05 was considered significant. 
Post-hoc analysis was done using Tukey’s Honestly Sig-
nificant difference (HSD) test. All curves were produced 
using Microsoft® Office Excel (Microsoft Corporation, 
USA) and the Y-axis error bars represent P<0.05. 
2  Results 
2.1  Prohibitin is up-regulated in MHCC97-H cells  
Figure 1 shows enlarged 2-DE images of the PHB proteins 
from Chang liver and MHCC97-H cells captured by WGA. 
The spots were analyzed using ImageMaster™ 2-D Plati-
num software and the results showed that PHB was up-       
regulated (2.64±0.12)-fold in MHCC97-H cells compared 
with Chang liver cells (P<0.05). The prohibitin spots were 
cut from CBB R250 stained gels for identification using 
MALDI-TOF MS. Figure 2 shows the identification pro-
hibitin by PMF and MS/MS and Figure 2A shows the mass 
fingerprints. The product ion spectra of the tryptic peptides 
T-(1–10) FDAGELITQR at m/z 1149.6158 and T-(1–12) 
ILFRPVASQLPR at m/z 1396.8728 are shown in Figure 2B 
and C, respectively. MASCOT searching indicated that 10 
and 12 peptides matched the peptides identified from the 
spots. The sequence coverage was 79%. The MASCOT 
score was as high as 422 (P<0.05), implying significant 
confidence levels for the identification. Both the MS and 
MS/MS analyses showed that the best match for the protein 
spot was prohibitin [10].  
We confirmed that PHB was up-regulated in MHCC97-H 
cells using RT-PCR and western blotting. RT-PCR showed 
that PHB mRNA levels increased (1.80±0.12)-fold in 
MHCC97-H cells compared with Chang liver cells (P<0.05; 
Figure 3A). After lysis of the cells, the extracts were ana-
lyzed by western blotting. The results showed that PHB was 
up-regulated (2.00±0.12)-fold in MHCC97-H cells com-
pared with Chang liver cells (P<0.05) (Figure 3B). These 
results showed that PHB was up-regulated at both the tran-
scriptional and translational levels.  
2.2  PHB is associated with the migration of liver can-
cer cells 
MHCC97-H and MHCC97-L cells were established from 
the parent cell line, MHCC97. The two daughter cell lines 
had the same genetic background, but different metastatic  
 
 
Figure 1  Comparative analysis of PHB expression in 2-DE gels. The 
up-regulated spots are shown in the enlarged images of the 2-DE gels. 
Upper panel, PHB protein spots; lower panel, spot analysis using Image-
Master™ 2-D Platinum software. The relative abundance is shown as a 
3-dimensional simulation. The Y axis indicates the over-expression of PHB 
protein relative to the control (Chang liver cells). Data are expressed as the  
mean±SD (n=3). *, P<0.05 (compared with Chang liver cells). 
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Figure 2  Identification of prohibitin protein by PMF and MS/MS. A, MALDI peptide mass fingerprint of prohibitin. B, The product ion spectra of the 
tryptic peptide T-(1–10) FDAGELITQR at m/z 1149.6158 from prohibitin. The ion score was 91 and the sequence coverage reached 79%. C, The product  
ion spectra of the tryptic peptide T-(1–12) ILFRPVASQLPR at m/z 1396.8728 from prohibitin. The ion score was 59. 
potential. Spontaneous pulmonary metastasis occurred in 
100% and 40% of recipient nude mice after orthotopic in-
oculation of MHCC97-H and MHCC97-L cells, respec-
tively [14,15]. Therefore, we wondered whether PHB was 
over-expressed in MHCC97-L cells. The results showed 
that the expression level of PHB in MHCC97-L cells was 
not significantly higher than that in Chang liver cells (Fig-
ure 3).  
However, we did notice different expression levels of 
PHB between MHCC97-L and MHCC97-H cells. Figure 3B 
shows that the expression level of PHB in MHCC97-H cells 
was 1.50±0.04 times higher than that in MHCC97-L cells 
(P<0.05). This suggested that up-regulation of PHB may be 
involved in the metastasis of liver cancer cells. 
2.3  The influence of PHB over-expression on the pro-
liferation and migration of MHCC97-L cells 
Compared with MHCC7-H cells, the expression level of 
PHB in MHCC97-L cells was low. Therefore, we used  
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Figure 3  Comparative analysis of PHB mRNA and protein levels in 
Chang liver cells and MHCC97-H cells. A, Semi-quantitative RT-PCR of 
PHB mRNA from Chang liver and MHCC97-H cells. Lane 1, marker; 
lanes 2 and 3, actin; lanes 4 and 5, PHB; M, marker; C, Chang liver cells; 
H, MHCC97H cells. The Y axis indicates the over-expression of PHB 
mRNA relative to the control (Chang liver cells). Data are expressed as the 
mean±SD (n=3); *, P<0.05 (compared with Chang liver cells). B, Western 
blot of PHB from Chang liver, MHCC97-L and MHCC97-H cells. Upper 
panel, PHB protein; lower panel, GADPH. The Y axis indicates the 
over-expression of the PHB protein relative to the control (Chang liver 
cells). Data are expressed as the mean±SD (n=3); *P<0.05 (compared with  
Chang liver cells). 
MHCC97-L cells to study the influence of PHB on the pro-
liferation and migration of liver cancer cells. First, we con-
structed the pcDNA3.0-PHB plasmid (Figure 4A). After 
transfection of the plasmid into MHCC97-L cells, we found 
that PHB was up-regulated (1.60±0.10)-fold (P<0.05) (Fig-
ure 4B). As it was reported that over-expression of PHB 
could inhibit the proliferation of breast epithelial cells [16], 
we used an MTT assay to study the influence of PHB 
over-expression on MHCC97-L cell proliferation. The re-
sults showed a 35% inhibition of cell proliferation that 
lasted up to 72 h after the transfection (Figure 5). This sug-
gested that PHB also played a role in inhibiting MHCC97-L 
cell proliferation. 
There are few reports regarding the association of PHB 
with the migration of hepatocellular carcinoma cells. The  
 
Figure 4  Construction of the PHB over-expression plasmid. A, Left, 
PHB PCR product amplified from the cDNA of Chang lover cells; Right, 
PHB cDNA after cutting pcDNA 3.0-PHB with Xba I and BamH I. M, 
marker; Con, PCR product from control. B, PHB over-expression in trans-
fected MHCC97-L cells was examined by Western blotting. The Y axis 
indicates the level of the up-regulated PHB protein relative to the control 
(MHCC97-L cells). Data are expressed as the mean±SD (n=3); *, P<0.05  
(compared with MHCC97-L cells). 
 
Figure 5  Over-expression of PHB inhibited the proliferation of 
MHCC97-L cells. MHCC97L cells were cultured in 96-well plates after 
transfection with pcDNA 3.0-PHB for 24 h. Proliferation assessed using an  
MTT assay. 
metastatic efficiency of tumor cells is evaluated using cell 
migration assays. Therefore, we assessed the migration of 
MHCC97-L cells using transwell migration assays. The  
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Figure 6  Increased MHCC97-L cell migration induced by over-expre-    
ssion of PHB. The Y axis indicates the number of cells counted within each 
field (8 fields for each group). Data are expressed as the mean±SD. *,  
P<0.05 (compared with the MHCC97-L group). 
micrographs of a typical transwell experiment (Figure 6) in-
dicated that the migration of pcDNA3.0-PHB-transfected 
cells was 2.10±0.10 times higher than that of the pcDNA3.0-     
transfected cells (P<0.05). This suggested that up-regulation 
of PHB promoted the migration of MHCC97-L cells. 
3  Discussion 
The results of this study showed that PHB was over-ex-     
pressed in liver cancer cells and inhibited the proliferation, 
and promoted the migration, of these cells. This raises sev-
eral questions regarding the over-expression of PHB in tu-
mor cells. PHB was believed to be a mitochondrial chaper-
one indirectly related to the aging process and carcinogene-
sis through its effects on the stability of newly encoded mi-
tochondrial proteins and the subsequent assembly of respi-
ratory chain complexes. Given that PHB levels appear to 
decrease during cellular senescence, it is conceivable that 
over-expression of PHB might extend the life span of tumor 
cells, which could be a critical step in the establishment of 
tumorigenic clones during the early stages of carcinogenesis 
[17]. Nijtmans et al. [2] provided an alternative explanation 
for the association between PHB over-expression and pro-
liferation. They suggested that it was because of the pres-
ence of regulatory elements within the PHB promoter that 
bind to the Myc oncoprotein. Up-regulated Myc expression, 
which is common in proliferating cells, induces the expres-
sion of PHB.  
Tumor cell migration is a major cause of mortality in 
cancer patients. Altered expression of cellular adhesion 
molecules is critical for the migration of primary tumors to 
the liver. Loss of E-cadherin and increased expression of 
CD44 variant 6 are associated with hepatic migration and a 
poor prognosis for primary colorectal liver metastases [18]. 
In a study of cervical adenocarcinomas, high PHB expres-
sion was found in 51 of 69 (73.9%) invasive adenocarci-
noma cases and in 11 of 16 (68.7%) adenocarcinoma in situ 
lesions. PHB over-expression was significantly higher in 
invasive adenocarcinoma and adenocarcinoma in situ tis-
sues than in the adjacent non-neoplastic glandular epithe-
lium [17]. Rajalingam et al. [19] identified an unexpected 
role for PHB in the activation of the Ras-Raf signaling 
pathway and in the modulation of epithelial cell adhesion 
and migration. In our experiments, we found that PHB was 
up-regulated in MHCC97-H cells with a high migration 
potential, and that over-expression of PHB induced the mi-
gration of these cells. This indicates that over-expression of 
PHB might be specifically associated with the migration of 
liver cancer cells. Knockdown of PHB using RNAi would 
confirm the effect of PHB on the proliferation and migra-
tion of MHCC97-H cells. Unfortunately, it was not possible 
to transfect MHCC97-H cells with PHB RNAi in this study. 
To the best of our knowledge, this is the first report de-
tailing the capture and identification of PHB from cancer 
cells using WGA. WGA recognizes N-acetyl-glucosamine 
(GlcNAc) and, also, has affinity for sialic acid (it has affin-
ity for complex N-type tri and tetraantennary-oligosaccha-       
rides). In this study, WGA captured more PHB from 
MHCC97H cells than from Chang liver cells. This indicates 
that PHB was either over-expressed in MHCC97-H cells, or 
that it contains more complex N-type tri- and tetraanten-
nary-oligosaccharides in these cells. Although our data 
showed that PHB was up-regulated in liver cancer cells, it is 
still possible that this resulted from differences in the glycan 
content and structure of PHB between Chang liver cells and 
MHCC97-cells. Studies looking at the function and struc-
ture of the glycans within PHB are ongoing. 
Although knowledge about the function of PHB in can-
cer is limited, our results clearly show that PHB is 
up-regulated in MHCC97-H cells and plays an important 
role in the proliferation and migration of liver cancer cells. 
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